The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2018 1
2016 1
2007 1

Panama 1

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine

CITE Title : Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine Personal Author(s) : Brickley, Elizabeth B;Strauch, Carolyn B;Wieland-Alter, Wendy F;Connor, Ruth I;Lin, Shu;Weiner, Joshua A;Ackerman, Margaret E;Arita, Minetaro;Oberste, M Steven;Weldon, William C;Sáez-Llorens, Xavier;Bandyopadhyay, Ananda S;Wright, Peter F; Published Date : Jan 17 2018 Source : J Infect Dis. 2018; 217(3):371-380. URL : https://stacks.cdc.gov/view/cdc/52804 Brickley, Elizabeth B et al. (2018). Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine. 217(3). Brickley, Elizabeth B et al. "Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine" 217, no. 3 (2018) Brickley, Elizabeth B et al. "Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine" vol. 217, no. 3, 2018 Export RIS Citation Information.

:

Brickley, Elizabeth B ;

Strauch, Carolyn B

Jan 17 2018 | J Infect Dis. 2018; 217(3):371-380.

:

BackgroundThe impact of inactivated polio vaccines (IPVs) on intestinal mucosal immune responses to live poliovirus is poorly understood.MethodsIn a 2...
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial

CITE Title : Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial Personal Author(s) : Sáez-Llorens, Xavier;Clemens, Ralf;Leroux-Roels, Geert;Jimeno, José;Clemens, Sue Ann Costa;Weldon, William C;Oberste, M Steven;Molina, Natanael;Bandyopadhyay, Ananda S; Published Date : 3 2016 Source : Lancet Infect Dis. 16(3):321-330 URL : https://stacks.cdc.gov/view/cdc/117615 Sáez-Llorens, Xavier et al. (2016). Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial. 16(3). Sáez-Llorens, Xavier et al. "Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial" 16, no. 3 (2016) Sáez-Llorens, Xavier et al. "Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial" vol. 16, no. 3, 2016 Export RIS Citation Information.

:

Sáez-Llorens, Xavier ;

Clemens, Ralf

3 2016 | Lancet Infect Dis. 16(3):321-330

:

BackgroundFollowing the proposed worldwide switch from trivalent oral poliovirus vaccine (tOPV) to bivalent types 1 and 3 OPV (bOPV) in 2016, inactiva...
Rocky Mountain Spotted Fever, Panama

CITE Title : Rocky Mountain Spotted Fever, Panama Personal Author(s) : Estripeaut, Dora;Aramburú, María Gabriela;Sáez-Llorens, Xavier;Thompson, Herbert A.;Dasch, Gregory A.;Paddock, Christopher D.;Zaki, Sherif;Eremeeva, Marina E.; Published Date : Nov 2007 Source : Emerg Infect Dis. 13(11):1763-1765. URL : https://stacks.cdc.gov/view/cdc/10810 Estripeaut, Dora et al. (2007). Rocky Mountain Spotted Fever, Panama. 13(11). Estripeaut, Dora et al. "Rocky Mountain Spotted Fever, Panama" 13, no. 11 (2007) Estripeaut, Dora et al. "Rocky Mountain Spotted Fever, Panama" vol. 13, no. 11, 2007 Export RIS Citation Information.

:

Estripeaut, Dora ;

Aramburú, María Gabriela

Nov 2007 | Emerg Infect Dis. 13(11):1763-1765.

:

We describe a fatal pediatric case of Rocky Mountain spotted fever in Panama, the first, to our knowledge, since the 1950s. Diagnosis was established ...
Meningococcal disease in North America: Updates from the Global Meningococcal Initiative

CITE Title : Meningococcal disease in North America: Updates from the Global Meningococcal Initiative Personal Author(s) : Asturias, Edwin J.;Bai, Xilian;Bettinger, Julie A.;Borrow, Ray;Castillo, Delia Nais;Caugant, Dominique A.;Chacon, Grettel Chanto;Dinleyici, Ener Cagri;Echaniz-Aviles, Gabriela;Garcia, Luis;Glennie, Linda;Harrison, Lee H.;Howie, Rebecca L.;Itsko, Mark;Lucidarme, Jay;Marin, Jose Eduardo Oliva;Marjuki, Henju;McNamara, Lucy A.;Mustapha, Mustapha M.;Robinson, Joan L.;Romeu, Belkis;Sadarangani, Manish;Sáez-Llorens, Xavier;Sáfadi, Marco A.P.;Stephens, David S.;Stuart, James M.;Taha, Muhamed-Kheir;Tsang, Raymond S.W.;Vazquez, Julio;De Wals, Philippe; Published Date : 12 2022 Source : J Infect. 85(6):611-622 URL : https://stacks.cdc.gov/view/cdc/156502 Asturias, Edwin J. et al. (2022). Meningococcal disease in North America: Updates from the Global Meningococcal Initiative. 85(6). Asturias, Edwin J. et al. "Meningococcal disease in North America: Updates from the Global Meningococcal Initiative" 85, no. 6 (2022) Asturias, Edwin J. et al. "Meningococcal disease in North America: Updates from the Global Meningococcal Initiative" vol. 85, no. 6, 2022 Export RIS Citation Information.

:

Asturias, Edwin J. ;

Bai, Xilian

12 2022 | J Infect. 85(6):611-622

:

This review summarizes the recent Global Meningococcal Initiative (GMI) regional meeting, which explored meningococcal disease in North America. Invas...